Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis-Reference-Cited by-同舟云学术

Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis

Published:2024-02 Issue: Volume:1233 Page:123980
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Gasthuys Elke,van Ovost Judith,Vande Casteele Sofie,Cosyns Sarah,Ceelen Wim,Van Bocxlaer Jan,Vermeulen An

Funder

Kom op tegen Kanker

Publisher

Elsevier BV

Reference23 articles.

1. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics;Goldwirt;J. Pharm. Biomed. Anal.,2012

2. Population pharmacokinetics of CPT-11 (irinotecan) in gastric cancer patients with peritoneal seeding after its intraperitoneal administration;Ahn;Eur. J. Clin. Pharmacol.,2010

3. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins;Garcia-Carbonero;Clin. Can. Res. off. J. Am. Assoc. Can. Res.,2002

4. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11);Mathijssen;Clin. Can. Res. Off. J. Am. Assoc. Can. Res.,2001

5. Human carboxylesterases: a comprehensive review;Wang;Acta Pharm. Sin. B,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A validated high‐performance liquid chromatography‐tandem mass spectrometry method for simultaneous determination of irinotecan and two major metabolites in rat plasma: Application for the pharmacokinetics study;SEPARATION SCIENCE PLUS;2024-05-10